Dermatophagoides Farinae Drops(Wolwo Bio-Pharma)

The sponsor hopes to expand the population to conduct a multicenter, randomized, double-blind, placebo-controlled Phase III clinical study to further examine the clinical efficacy and safety of "dust mite drops" for adult atopic dermatitis caused by dust mite allergy, evaluate the benefit-risk relationship, and ultimately provide sufficient basis for the review of the drug registration application.